Skip to content

A study to compare hyperbaric levobupivacaine versus hyperbaric ropivacaine in pregnant women undergoing elective caesarean section

A comparative evaluation of Hyperbaric Levobupivacaine versus Hyperbaric Ropivacaine in parturients for elective caesarean section under spinal anaesthesia : A randomized clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/062143
Enrollment
132
Registered
2024-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Ropivacaine Heavy: Clinical efficacy and safety in parturients undergoing elective caesarean section. Total duration of the study is till the time when motor block returns to bromage 2.

Sponsors

Dr Sophia Koyu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) American Society of Anesthesiologists (ASA) physical status II. 2) Singleton term pregnancy

Exclusion criteria

Exclusion criteria: 1. History of allergy to study drugs, pregnancy induced hypertension, cardiovascular co-morbidities, central nervous system disease. 2. Bleeding tendency, local site infection. 3. Weight 110kg, height 180cm. 4. Uncooperative, cardiac, respiratory diseases and kidney disorder, neurological deficit, spinal deformity.

Design outcomes

Primary

MeasureTime frame
Hemodynamic changes (SBP, DBP, MAP, HR), Sensory block characteristics (Time to adequate block level - t6 or t4/ sensory onset time, maximun sensory block level, time to peak sensory block level, time to two segment regression), Motor block characteristics (time to onset of motor block, time to reach bromage 3, duration of motor blockade), Side effects (hypotension, nausea, vomiting , others)Timepoint: Baseline, every 2minutes till 10minutes, every 5 minutes till 60 mins, every 15minutes till 120mins, every 30 minutes till 180 minutes.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sophia Koyu

Regional Institute of Medical Sciences

drchaoba@gmail.com8415091663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026